• 点赞
  • 评论
  • 收藏

IDEAYA生物科学公司开始针对B7H3和PTK7的IDE034一期临床试验,用于晚期实体瘤IDEAYA Biosciences Begins Phase 1 Trial of IDE034 Targeting B7H3 and PTK7 in Advanced Solid Tumors

动脉网02-25

by GOAI由GOAI生成Share To分享到IDEAYA Biosciences has initiated its Phase 1 clinical trial for IDE034, a bispecific antibody-drug conjugate (ADC) targeting B7H3 and PTK7. The company announced that the ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论

empty
暂无评论
 
 
 
 

热议股票

 
 
 
 
 

7x24